Abound Wealth Management
- SEC CIK
- 0001950323
- Latest filing
- Jul 10, 2026
CORT holding history
Corcept Therapeutics Inc in every 13F filed by Abound Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CORT overviewAll 13F holders of CORTFull Q2 2026 holdings
- Shares (Q2 2026)
- 4
- Value
- $348
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4 | $348 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 4 | $162 | <0.1% | −1−20.0% | Reduced | Holders |
| Q4 2025 | 5 | $174 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 5 | $416 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 5 | $367 | <0.1% | −1−16.7% | Reduced | Holders |
| Q1 2025 | 6 | $686 | <0.1% | −2−25.0% | Reduced | Holders |
| Q4 2024 | 8 | $404 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 8 | $371 | <0.1% | −4−33.3% | Reduced | Holders |
| Q2 2024 | 12 | $390 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 12 | $303 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 12 | $390 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 12 | $327 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 12 | $267 | <0.1% | +12 | New | Holders |